Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.
Official title: A Phase 1, Randomized, Double-blind, Positive-controlled, Placebo-controlled, 4-Period Crossover, Thorough QT/QTc Study to Evaluate the Effect of Multiple Doses of BMS-986278 on Cardiac Repolarization in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2026-02-19
Completion Date
2026-06-15
Last Updated
2026-03-17
Healthy Volunteers
Yes
Conditions
Interventions
BMS-986278
Specified dose on specified days
Placebo
Specified dose on specified days
Moxifloxacin
Specified dose on specified days
Locations (1)
Worldwide Clinical Trials
San Antonio, Texas, United States